Coverart for item
The Resource Pocket Reference to Osteoporosis, Serge Livio Ferrari, Christian Roux, editors, (electronic book)

Pocket Reference to Osteoporosis, Serge Livio Ferrari, Christian Roux, editors, (electronic book)

Label
Pocket Reference to Osteoporosis
Title
Pocket Reference to Osteoporosis
Statement of responsibility
Serge Livio Ferrari, Christian Roux, editors
Contributor
Subject
Language
eng
Cataloging source
EBLCP
Dewey number
616.7/16
Index
no index present
LC call number
RC931.O73
Literary form
non fiction
Nature of contents
dictionaries
http://library.link/vocab/relatedWorkOrContributorName
  • Ferrari, Serge Livio
  • Roux, Christian
http://library.link/vocab/subjectName
Osteoporosis
Label
Pocket Reference to Osteoporosis, Serge Livio Ferrari, Christian Roux, editors, (electronic book)
Instantiates
Publication
Note
Description based upon print version of record
Antecedent source
file reproduced from an electronic resource
Contents
  • Intro; Preface; Contents; Contributors; Chapter 1: Pathophysiology of Osteoporosis; 1.1 Introduction; 1.2 The Pathophysiological Bases of Osteoporosis; 1.3 The Role of Osteoclasts; 1.3.1 Control of Bone Resorption; 1.4 The Role of Osteoblasts; 1.4.1 Control of Bone Formation; 1.5 Conclusion; References; Chapter 2: Diagnosis and Clinical Aspects of Osteoporosis; 2.1 Introduction; 2.2 Diagnosing Osteoporosis; 2.3 Osteoporotic Fractures; 2.3.1 Hip Fracture; 2.3.2 Vertebral Fracture; 2.3.3 Distal Forearm Fracture; 2.3.4 All Fractures; 2.4 Burden of Disease; 2.5 Conclusion; References
  • Chapter 3: Evaluation of Fracture Risk3.1 Introduction; 3.2 Non-invasive Skeletal Assessments; 3.2.1 Measurements of Bone Mass; 3.2.2 Measurements of Bone Structure; 3.2.3 Measurements of Bone Turnover; 3.3 Assessment of Fracture Risk; 3.4 Conclusion; References; Chapter 4: Prevention of Osteoporosis and Fragility Fractures; 4.1 Introduction; 4.2 Physical Activity; 4.3 Prevention of Falls; 4.3.1 Intrinsic Factors; 4.3.2 Environmental (Extrinsic) Risk Factors; 4.4 Nutrition; 4.4.1 Calcium and Vitamin D; 4.5 Conclusion; References; Chapter 5: Efficacy and Safety of Osteoporosis Treatment
  • 5.1 Introduction5.2 Bisphosphonates; 5.3 Estrogen Agonist/Antagonists; 5.4 Denosumab; 5.5 Teriparatide; 5.6 Choosing Among Therapies; 5.7 Conclusion; References; Chapter 6: Management of Patients with Increased Fracture Risk; 6.1 Introduction; 6.2 Treatment for Younger Women (Early 50s to Mid or Late 60s) with Osteoporosis by Bone Mineral Density But No Fractures; 6.3 Treatment for Older Women (Late 60s and Beyond) with Osteoporosis by Bone Mineral Density or an Isolated Fracture (Especially if More Remote); 6.4 Patients with Severe Osteoporosis at High Risk for Fractures
  • 6.5 Combination Therapy6.6 When Is Stopping Osteoporosis Treatment Reasonable?; 6.7 Resumption of Treatment After Medication Holiday; 6.8 Conclusion; References; Chapter 7: Management of Male Osteoporosis; 7.1 Introduction; 7.2 Case Finding; 7.2.1 Men with a History of Fracture; 7.2.2 Men Without a History of Fracture; 7.3 Risk Evaluation; 7.3.1 Men with a History of Fracture; 7.3.2 Men Without a History of Fracture; 7.4 Differential Diagnosis; 7.5 Treatment; 7.6 Follow-Up; 7.7 Conclusion; References; Chapter 8: Management of Glucocorticoid-Induced Osteoporosis; 8.1 Introduction
  • 8.2 Fracture Risk8.3 Management of Patients with Glucocorticoid-Induced Osteoporosis; References; Chapter 9: New Bone-Forming Agents; 9.1 Introduction; 9.2 Parathyroid Hormone-Related Peptides; 9.3 Sclerostin Inhibitors; 9.4 Conclusion; References; Index
Dimensions
unknown
Extent
1 online resource (103 p.)
File format
one file format
Form of item
online
Isbn
9783319267555
Level of compression
unknown
Quality assurance targets
unknown
Reformatting quality
unknown
Specific material designation
remote
System control number
  • on1081000198
  • (OCoLC)1081000198
Label
Pocket Reference to Osteoporosis, Serge Livio Ferrari, Christian Roux, editors, (electronic book)
Publication
Note
Description based upon print version of record
Antecedent source
file reproduced from an electronic resource
Contents
  • Intro; Preface; Contents; Contributors; Chapter 1: Pathophysiology of Osteoporosis; 1.1 Introduction; 1.2 The Pathophysiological Bases of Osteoporosis; 1.3 The Role of Osteoclasts; 1.3.1 Control of Bone Resorption; 1.4 The Role of Osteoblasts; 1.4.1 Control of Bone Formation; 1.5 Conclusion; References; Chapter 2: Diagnosis and Clinical Aspects of Osteoporosis; 2.1 Introduction; 2.2 Diagnosing Osteoporosis; 2.3 Osteoporotic Fractures; 2.3.1 Hip Fracture; 2.3.2 Vertebral Fracture; 2.3.3 Distal Forearm Fracture; 2.3.4 All Fractures; 2.4 Burden of Disease; 2.5 Conclusion; References
  • Chapter 3: Evaluation of Fracture Risk3.1 Introduction; 3.2 Non-invasive Skeletal Assessments; 3.2.1 Measurements of Bone Mass; 3.2.2 Measurements of Bone Structure; 3.2.3 Measurements of Bone Turnover; 3.3 Assessment of Fracture Risk; 3.4 Conclusion; References; Chapter 4: Prevention of Osteoporosis and Fragility Fractures; 4.1 Introduction; 4.2 Physical Activity; 4.3 Prevention of Falls; 4.3.1 Intrinsic Factors; 4.3.2 Environmental (Extrinsic) Risk Factors; 4.4 Nutrition; 4.4.1 Calcium and Vitamin D; 4.5 Conclusion; References; Chapter 5: Efficacy and Safety of Osteoporosis Treatment
  • 5.1 Introduction5.2 Bisphosphonates; 5.3 Estrogen Agonist/Antagonists; 5.4 Denosumab; 5.5 Teriparatide; 5.6 Choosing Among Therapies; 5.7 Conclusion; References; Chapter 6: Management of Patients with Increased Fracture Risk; 6.1 Introduction; 6.2 Treatment for Younger Women (Early 50s to Mid or Late 60s) with Osteoporosis by Bone Mineral Density But No Fractures; 6.3 Treatment for Older Women (Late 60s and Beyond) with Osteoporosis by Bone Mineral Density or an Isolated Fracture (Especially if More Remote); 6.4 Patients with Severe Osteoporosis at High Risk for Fractures
  • 6.5 Combination Therapy6.6 When Is Stopping Osteoporosis Treatment Reasonable?; 6.7 Resumption of Treatment After Medication Holiday; 6.8 Conclusion; References; Chapter 7: Management of Male Osteoporosis; 7.1 Introduction; 7.2 Case Finding; 7.2.1 Men with a History of Fracture; 7.2.2 Men Without a History of Fracture; 7.3 Risk Evaluation; 7.3.1 Men with a History of Fracture; 7.3.2 Men Without a History of Fracture; 7.4 Differential Diagnosis; 7.5 Treatment; 7.6 Follow-Up; 7.7 Conclusion; References; Chapter 8: Management of Glucocorticoid-Induced Osteoporosis; 8.1 Introduction
  • 8.2 Fracture Risk8.3 Management of Patients with Glucocorticoid-Induced Osteoporosis; References; Chapter 9: New Bone-Forming Agents; 9.1 Introduction; 9.2 Parathyroid Hormone-Related Peptides; 9.3 Sclerostin Inhibitors; 9.4 Conclusion; References; Index
Dimensions
unknown
Extent
1 online resource (103 p.)
File format
one file format
Form of item
online
Isbn
9783319267555
Level of compression
unknown
Quality assurance targets
unknown
Reformatting quality
unknown
Specific material designation
remote
System control number
  • on1081000198
  • (OCoLC)1081000198

Library Locations

Processing Feedback ...